News & Updates

Show Multimedia Only
ARBs a good alternative to ACEIs in patients with acute MI

ARBs a good alternative to ACEIs in patients with acute MI

20 Nov 2024

The incidence of death is comparable between patients with acute myocardial infarction (MI) without heart failure (HF) receiving angiotensin II receptor blockers (ARBs) and those taking angiotensin-converting enzyme inhibitors (ACEIs), a study has shown.

20 Nov 2024
Prompt DOAC therapy after stroke safe for AF patients

Prompt DOAC therapy after stroke safe for AF patients

11 Nov 2024 byJairia Dela Cruz

Initiating direct oral anticoagulants (DOACs) within 4 days after an ischaemic stroke in patients with atrial fibrillation (AF) is safe and yields similar outcomes as delayed initiation, as shown in the phase 4 OPTIMAS trial.

11 Nov 2024